COVID-19

Researchers around the world are on a mission to bank biological samples from millions of people. So far, these efforts have disclosed the effects of arsenic exposure on the genome, supported development of early cancer diagnostics, and even revealed the ideal timing for COVID-19 boosters.

CRISPR biosensing technology provides unambiguous pathogen detection.

Automated synthetic biology workflows enable efficient mRNA-based therapeutic development.

Advanced diagnostic devices hold potential for achieving precision healthcare.

What do 23andMe and Snapchat have in common? They both collect very personal information about their users. Do the benefits outweigh the risks?

People with COVID-19 sometimes lose their sense of smell. But a clinical researcher has a possible solution: the patient’s own blood.

Anna Blakney, an RNA bioengineer and TikTok science communicator, studies how self-amplifying RNA improves RNA vaccines and therapeutics.

It’s human nature to compare one’s success to others, but thinking that the grass is greener on the other side can be detrimental to one’s health. Recognizing strategies as equal but unique ways to tackle a common problem is a healthier perspective.

Learn how scientists detect viral pathogens lurking in the environment to mitigate infectious disease threats. 

Inspired by toys from her childhood, bioengineer Michelle Khine designs microscale diagnostics and wearable biosensors with the hope of revolutionizing how people monitor their health.